Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Eli Lilly and Co. is suing an Indianapolis-based weight-loss clinic it says is improperly selling Lilly’s hugely popular diabetes and weight-loss drugs.

Eli Lilly and Co. is suing an Indianapolis-based ... Zepbound and Mounjaro are sold in sterile, single-use auto-injector pens or in single-dose vials. However, in the latest complaint, Lilly ...

Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from ... Its injectable drugs require both specialized injection pens and cold storage and shipping, so manufacturing and transport are often ...

The firm thinks Hims & Hers is offering the auto-injector pens for $1,900 per month, and not the lower priced Tirzepatide vials, which are priced as low as $349 per month on Eli Lilly’s (LLY ...

Eli Lilly announced Tuesday single-dose vials ... Plus, you won't need the auto-injector pens for these vials. "The biggest limitation has been the cost," said Dr. Srinivasu Kesa with MD Wellness ...

Mounjaro, a weight loss drug launched by Eli Lilly in India ... A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes in the US on March 29 ...

Eli Lilly says Indianapolis-based Premier Weight Loss is cracking open auto-injector pens containing its blockbuster drug and repackaging them into separate doses. The latest threat to Eli Lilly’s ...

In a step towards making the drugs more affordable, Eli Lilly announced that its weight ... drug in single-use vials rather than the auto-injector pens. This decision will also increase ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.